Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitafloxacin + metronidazole + vonoprazan 10‑day regimen for H. pylori eradication in penicillin-allergic or previously treated patients
jRCTs031180412Completed
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of vonoprazan, metronidazole and sitafloxacin in Helicobacter pylori infection. Primary endpoint: H. pylori eradication rate. Started May 2016; status: completed.
02
Drugs
vonoprazanmetronidazolesitafloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on jRCTs031180412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180412.